Simone Parisi

2.4k total citations
61 papers, 578 citations indexed

About

Simone Parisi is a scholar working on Rheumatology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Simone Parisi has authored 61 papers receiving a total of 578 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Rheumatology, 14 papers in Immunology and 12 papers in Pathology and Forensic Medicine. Recurrent topics in Simone Parisi's work include Rheumatoid Arthritis Research and Therapies (22 papers), Spondyloarthritis Studies and Treatments (10 papers) and Systemic Sclerosis and Related Diseases (10 papers). Simone Parisi is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (22 papers), Spondyloarthritis Studies and Treatments (10 papers) and Systemic Sclerosis and Related Diseases (10 papers). Simone Parisi collaborates with scholars based in Italy, United States and Belgium. Simone Parisi's co-authors include Enrico Fusaro, Maria Chiara Ditto, Alarico Ariani, Carlo Alberto Scirè, Piercarlo Sarzi‐Puttini, Nicola Ughi, M. Manara, I. Prevete, Alessandra Bortoluzzi and Fausto Salaffi and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Simone Parisi

56 papers receiving 566 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Simone Parisi Italy 12 212 146 81 77 64 61 578
Mansoor Karimifar Iran 13 245 1.2× 98 0.7× 127 1.6× 57 0.7× 52 0.8× 49 591
Tim Holbrook United Kingdom 9 132 0.6× 142 1.0× 92 1.1× 41 0.5× 21 0.3× 37 643
Feride Göğüş Türkiye 12 376 1.8× 87 0.6× 66 0.8× 124 1.6× 36 0.6× 41 718
Michele Hooper United States 12 200 0.9× 189 1.3× 49 0.6× 94 1.2× 94 1.5× 16 506
Şebnem Ataman Türkiye 11 263 1.2× 93 0.6× 60 0.7× 109 1.4× 21 0.3× 44 514
Robert Quinet United States 15 244 1.2× 200 1.4× 106 1.3× 33 0.4× 30 0.5× 40 693
Eleftherios Pelechas Greece 14 295 1.4× 139 1.0× 47 0.6× 68 0.9× 28 0.4× 63 542
Seyedeh Tahereh Faezi Iran 16 355 1.7× 107 0.7× 93 1.1× 47 0.6× 23 0.4× 59 639
Ahmet Omma Türkiye 14 253 1.2× 149 1.0× 42 0.5× 84 1.1× 33 0.5× 103 608
Şevket Ercan Tunç Türkiye 17 215 1.0× 69 0.5× 74 0.9× 43 0.6× 20 0.3× 46 585

Countries citing papers authored by Simone Parisi

Since Specialization
Citations

This map shows the geographic impact of Simone Parisi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simone Parisi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simone Parisi more than expected).

Fields of papers citing papers by Simone Parisi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simone Parisi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simone Parisi. The network helps show where Simone Parisi may publish in the future.

Co-authorship network of co-authors of Simone Parisi

This figure shows the co-authorship network connecting the top 25 collaborators of Simone Parisi. A scholar is included among the top collaborators of Simone Parisi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simone Parisi. Simone Parisi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Parisi, Simone, Mirko Parasiliti‐Caprino, Guglielmo Beccuti, et al.. (2025). Disease activity score is associated with vertebral fragility fractures in patients with rheumatoid arthritis: a cross-sectional multidisciplinary study. Rheumatology International. 45(5). 133–133. 1 indexed citations
2.
Parisi, Simone, et al.. (2025). Update on tocilizumab in rheumatoid arthritis: a narrative review. Frontiers in Immunology. 16. 1470488–1470488. 10 indexed citations
3.
Baldi, Caterina, Simone Parisi, Paolo Falsetti, et al.. (2024). Efficacy and Safety of Upadacitinib in Rheumatoid Arthritis: Real-Life Experience from a Prospective Longitudinal Multicentric Study. Journal of Clinical Medicine. 13(2). 401–401. 5 indexed citations
4.
Favalli, Ennio Giulio, Francesco Grossi, Alberto Batticciotto, et al.. (2024). Spondyloarthritis and Risk of Malignancy: A Narrative Review on a Still Controversial Issue. Rheumatology and Therapy. 12(1). 25–36.
5.
Biggioggero, Martina, Elisa Gremese, Serena Bugatti, et al.. (2023). POS0858 THE LONG-TERM RETENTION RATE OF JAK INHIBITORS IN RHEUMATOID ARTHRITIS: DATA FROM THE NATIONAL ITALIAN REGISTRY GISEA. 733–734. 1 indexed citations
6.
Parisi, Simone, Maria Chiara Ditto, Francesca Maletta, et al.. (2023). New Onset of Giant Cell Arteritis following ChAdOx1-S (Vaxevria®) Vaccine Administration. Vaccines. 11(2). 434–434. 4 indexed citations
7.
Manara, M., I. Prevete, Antonio Marchesoni, et al.. (2021). The Italian Society for Rheumatology recommendations for the management of axial spondyloarthritis. SHILAP Revista de lepidopterología. 73(2). 71–88. 6 indexed citations
8.
Ditto, Maria Chiara, Simone Parisi, Gian Paolo Caviglia, et al.. (2021). Intestinal microbiota changes induced by TNF-inhibitors in IBD-related spondyloarthritis. RMD Open. 7(3). e001755–e001755. 23 indexed citations
9.
Avenatti, Eleonora, Simone Parisi, Chiara Ballini, et al.. (2021). Cardiovascular Organ Damage in Clinical Subtypes of Systemic Sclerosis: Arterial Stiffness and Echocardiography Might Not Be the Ideal Tools for Patient Risk Stratification. Cardiology Research and Practice. 2021. 1–7. 2 indexed citations
10.
Ariani, Alarico, L. Bazzichi, Piercarlo Sarzi‐Puttini, et al.. (2021). The Italian Society for Rheumatology clinical practice guidelines for the diagnosis and management of fibromyalgia. Best practices based on current scientific evidence. SHILAP Revista de lepidopterología. 73(2). 89–105. 29 indexed citations
11.
Ditto, Maria Chiara, et al.. (2020). Rheumatic manifestations in inflammatory bowel disease. 1 indexed citations
12.
Ditto, Maria Chiara, Simone Parisi, Silvia Sanna, et al.. (2020). Efficacy and safety of a single switch from etanercept originator to etanercept biosimilar in a cohort of inflammatory arthritis. Scientific Reports. 10(1). 16178–16178. 12 indexed citations
13.
Ughi, Nicola, Gian Domenico Sebastiani, Roberto Gerli, et al.. (2020). The Italian Society of Rheumatology clinical practice guidelines for the management of polymyalgia rheumatica. SHILAP Revista de lepidopterología. 72(1). 1–15. 4 indexed citations
14.
Parisi, Simone, et al.. (2020). Viral arthritis and COVID-19. The Lancet Rheumatology. 2(11). e655–e657. 74 indexed citations
15.
Favalli, Ennio Giulio, Luca Idolazzi, Serena Bugatti, et al.. (2019). SAT0656 DAPSA OR MDA/VLDA CRITERIA FOR DEFINING THE TREATMENT TARGET IN PSORIATIC ARTHRITIS? CROSS-SECTIONAL ANALYSIS FROM A MULTICENTER ITALIAN COHORT. Annals of the Rheumatic Diseases. 78. 1426–1427. 1 indexed citations
16.
Ariani, Alarico, M. Manara, Antonella Fioravanti, et al.. (2019). The Italian Society for Rheumatology clinical practice guidelines for the diagnosis and management of knee, hip and hand osteoarthritis. Reumatismo. 71(S1). 5–21. 40 indexed citations
17.
Favalli, Ennio Giulio, Andrea Becciolini, Antonio Carletto, et al.. (2019). Efficacy and retention rate of adalimumab in rheumatoid arthritis and psoriatic arthritis patients after first-line etanercept failure: the FEARLESS cohort. Rheumatology International. 40(2). 263–272. 10 indexed citations
18.
Parisi, Simone, et al.. (2019). The clinical presentation in adulthood of juvenile idiopathic arthritis. Minerva Medica. 110(5). 450–454. 3 indexed citations
19.
Benucci, Maurizio, Francesca Li Gobbi, Francesca Bandinelli, et al.. (2016). Safety, efficacy and immunogenicity of switching from innovator to biosimilar infliximab in patients with spondyloarthritis: a 6-month real-life observational study. Immunologic Research. 65(1). 419–422. 44 indexed citations
20.
Furneri, Gianluca, et al.. (2015). The Cost of Rehumatoid Diseases In Italy: Analysis From An Italian Administrative Database. Value in Health. 18(7). A642–A642. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mansoor Karimifar Breakdown of academic impact, for papers by Tim Holbrook Breakdown of academic impact, for papers by Feride Göğüş Breakdown of academic impact, for papers by Michele Hooper Breakdown of academic impact, for papers by Şebnem Ataman Breakdown of academic impact, for papers by Robert Quinet Breakdown of academic impact, for papers by Eleftherios Pelechas Breakdown of academic impact, for papers by Seyedeh Tahereh Faezi Breakdown of academic impact, for papers by Ahmet Omma Breakdown of academic impact, for papers by Şevket Ercan Tunç
Rankless by CCL
2026